PluriSIn #2 is primarily utilized in research focused on stem cell biology and regenerative medicine. It plays a significant role in inducing pluripotency in somatic cells, which is crucial for generating induced pluripotent stem cells (iPSCs). These iPSCs have the potential to differentiate into various cell types, making them valuable for studying disease mechanisms, drug screening, and developing cell-based therapies. Additionally, PluriSIn #2 is explored for its ability to enhance the efficiency of reprogramming processes, reducing the time and improving the yield of pluripotent stem cells. Its application extends to tissue engineering and personalized medicine, where it aids in creating patient-specific cell lines for therapeutic purposes.